Danske Bank Group reduces stake in Medistim ASA below 5% threshold

Danske Bank Group announced a significant change in its ownership of Medistim ASA, crossing below the 5% disclosure threshold. As of September 11, 2025, the group's total aggregated holding in Medistim ASA stands at 895,181 shares, representing 4.88% of the total voting rights.

The ownership is distributed across several Danske Bank Group entities. Kapitalforeningen Danske Invest Institutional holds 2.64%. Other holdings include Danske Fund Luxembourg at 0.95%, SICAV at 0.39%, Danske Invest Engros at 0.38%, Finnish Fund at 0.30%, and Danske Invest at 0.22%.